Skip to content

SimulAID

Digital Twin Simulation of Uncomplicated Type B Aortic Dissection for predicting False Lumen Thrombosis - SimulAID

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58285
Enrollment
40
Registered
2025-11-14
Start date
2026-02-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Descending Aortic Dissection

Interventions

Digital Twin Computational Model, based on CTA and 4D flow MRI imaging. A fluid-structure interaction model of the aortic wall, intimal flap and true and false lumen will be used as computational mode

Sponsors

Rijnstate
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Uncomplicated Type B Dissection in the past 2 weeksAged 18 years or older at the time of informed consent signature

Exclusion criteria

Exclusion criteria: Participants with no signed informed consentScheduled surgical or endovascular treatment of Type B DissectionParticipants previously treated in their descending aorta, either open surgery or TEVARSeverely impaired renal function (eGFR < 30mL/min/1.74m2)Participants with traumatic aortic dissectionsParticipants with an established connective tissue disease, including but not limited to Marfans and Loeys-Dietz syndromePregnant women

Design outcomes

Primary

MeasureTime frame
Composite outcome of positive false lumen development: full thrombosis of the false lumen, or no false lumen diameter growth over 3-mm per year during one year follow-up. 

Secondary

MeasureTime frame
Quality of Life and physical and mental health status during 1-year follow-upPercentage of thrombosed false lumen during 1-year follow-upChange in volume of the false lumen during 1-year follow-upChange in maximal descending aortic diameter during 1-year follow-upChange in descending aortic volume during 1-year follow-upAortic-related mortality, hospital readmission, organ malperfusion, TEVAR

Countries

Netherlands

Contacts

Public ContactL Velde

Rijnstate

LvandeVelde@Rijnstate.nl0880057282

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 3, 2026